Hybrid Conferencee

International Conference on Vaccine Development and Infectious Disease Prevention (ICVDIDP - 26)

7th - 8th September 2026 | Florence, Italy

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Florence. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Florence event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Florence conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Florence, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Florence."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Innovations in Vaccine Development

This track focuses on the latest advancements in vaccine technology and development processes. It aims to explore novel approaches and methodologies that enhance vaccine efficacy and accessibility.

Track 02

Clinical Trials in Vaccine Research

This session will delve into the design, implementation, and outcomes of clinical trials for new vaccines. Participants will discuss challenges and best practices in evaluating vaccine safety and effectiveness.

Track 03

Immunological Mechanisms in Infectious Diseases

This track aims to elucidate the immunological responses to various infectious agents. It will cover topics such as immune evasion strategies employed by pathogens and the role of host immunity in disease outcomes.

Track 04

Public Health Strategies for Disease Prevention

This session will examine effective public health interventions aimed at preventing infectious diseases. Discussions will include vaccination campaigns, health education, and community engagement strategies.

Track 05

Novel Vaccines for Emerging Infectious Diseases

This track will highlight the development of vaccines targeting newly emerging infectious diseases. It will focus on the rapid response mechanisms and innovative technologies used in vaccine creation.

Track 06

Pathogen Biology and Vaccine Targeting

This session will explore the biological characteristics of various pathogens and how these traits influence vaccine design. Participants will discuss the implications of pathogen biology on vaccine efficacy and safety.

Track 07

Outbreak Prevention and Response Strategies

This track will focus on strategies for preventing and responding to infectious disease outbreaks. It will cover surveillance systems, rapid response frameworks, and the role of vaccines in outbreak control.

Track 08

Vaccine Safety and Public Perception

This session will address the critical aspects of vaccine safety and the factors influencing public perception. Discussions will include risk communication, misinformation, and strategies to enhance vaccine confidence.

Track 09

Disease Modeling and Predictive Analytics

This track will explore the use of disease modeling and predictive analytics in understanding infectious disease dynamics. Participants will discuss how these tools can inform vaccine development and public health interventions.

Track 10

Global Collaboration in Vaccine Research

This session will highlight the importance of international collaboration in vaccine research and development. It will focus on partnerships between governments, academia, and industry to address global health challenges.

Track 11

Ethical Considerations in Vaccine Development

This track will examine the ethical implications surrounding vaccine research and deployment. Discussions will include informed consent, equitable access, and the responsibilities of researchers and policymakers.